title: Hemorrhagic gastritis as a new dose-limiting toxicity of recombinant tumor necrosis factor.
authors.affiliation: Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA.
authors.forename: R L
authors.initials: RL
authors.lastname: Krigel
authors.forename: K A
authors.initials: KA
authors.lastname: Padavic-Shaller
authors.forename: A A
authors.initials: AA
authors.lastname: Rudolph
authors.forename: J D
authors.initials: JD
authors.lastname: Young
authors.forename: L M
authors.initials: LM
authors.lastname: Weiner
authors.forename: M
authors.initials: M
authors.lastname: Konrad
authors.forename: R L
authors.initials: RL
authors.lastname: Comis
mesh_terms: D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects; D005756:Gastritis / Q000139:chemically induced*; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha